Bio Protocol vs Kava — how do they compare? Bio Protocol trades at Rp514.34 (market cap Rp1,16T, Rp252,63M 24h volume), while Kava trades at Rp803.5 (market cap Rp866,79M, Rp146,51M 24h volume). The key difference: Bio Protocol is far larger — about 1338.3× Kava's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Kava's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Kava for 55 Days on average.
| BIO | KAVA | |
|---|---|---|
Market Cap | Rp1,16T | Rp866,79M |
Volume (24h) | Rp252,63M | Rp146,51M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 1,1B KAVA |
Typical Hold Time | 16 Days | 55 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →KAVA is a cross-chain DeFi lending platform that allows users to borrow USDX stablecoins and deposit a variety of cryptocurrencies to begin earning a yield. Built on the Cosmos blockchain, Kava makes use of a collateralized debt position (CDP) system to ensure stablecoin loans are always sufficiently collateralized.
Read more on KAVA →